Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnaire Consisting of 30 Questions 'EORTC QLQ-C30&#...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2022-08-01
|
| Series: | Forbes Tıp Dergisi |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=forbes&un=FJM-04274 |
| _version_ | 1797767529971580928 |
|---|---|
| author | Ali İhsan GEMİCİ İstemi SERİN Vedat Buğra EROL Mehmet Hilmi DOĞU İdris İNCE Rafet EREN Atakan TEKİNALP Volkan KARAKUŞ İklil Nur KOÇ EROL Zeynep Ece ARSLAN Zekiye Nur TAY Elif Nur TUNCER Ömür Gökmen SEVİNDİK |
| author_facet | Ali İhsan GEMİCİ İstemi SERİN Vedat Buğra EROL Mehmet Hilmi DOĞU İdris İNCE Rafet EREN Atakan TEKİNALP Volkan KARAKUŞ İklil Nur KOÇ EROL Zeynep Ece ARSLAN Zekiye Nur TAY Elif Nur TUNCER Ömür Gökmen SEVİNDİK |
| author_sort | Ali İhsan GEMİCİ |
| collection | DOAJ |
| description | Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnaire Consisting of 30 Questions 'EORTC QLQ-C30' and the Quality of Life Questionnaire Multiple Myeloma Module 'QLQ-MY20', we aimed to obtain data on quality of life in MM patients in a representative sample of the general population of our country.
Methods: One hundred sixty eight patients from 6 different centers followed between 2018-2020 were included in the study. The QLQ-C30, and the QLQ-MY20 questionnaires specific for MM patients were used and the results were reported statistically.
Results: Seventy eight (46%) of the patients were female, while 90 (54%) were male. The median age was 64 (22-84). When the findings were analysed, it was found that there was a greater effect on the symptom scale compared to the functional scale.
Conclusion: The importance of the treatment-related side effect management, together with the adequate administration of appropriate symptomatic treatment in holistic treatment management were emphasized as effective factors in terms of the QoL of patients with MM. |
| first_indexed | 2024-03-12T20:40:13Z |
| format | Article |
| id | doaj.art-72d32f8ee7ef496cb5937c20070d45bb |
| institution | Directory Open Access Journal |
| issn | 2757-5241 |
| language | English |
| last_indexed | 2024-03-12T20:40:13Z |
| publishDate | 2022-08-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Forbes Tıp Dergisi |
| spelling | doaj.art-72d32f8ee7ef496cb5937c20070d45bb2023-08-01T10:46:48ZengGalenos YayineviForbes Tıp Dergisi2757-52412022-08-013216517210.4274/forbes.galenos.2022.04274FJM-04274Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter StudyAli İhsan GEMİCİ0İstemi SERİN1Vedat Buğra EROL2Mehmet Hilmi DOĞU3İdris İNCE4Rafet EREN5Atakan TEKİNALP6Volkan KARAKUŞ7İklil Nur KOÇ EROL8Zeynep Ece ARSLAN9Zekiye Nur TAY10Elif Nur TUNCER11Ömür Gökmen SEVİNDİK12İstanbul Medipol University Faculty of Medicine, Department of Hematology, İstanbul, TurkeyUniversity of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkeyİstanbul Medipol University Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkeyİstinye University Faculty of Medicine, Liv Hospital Ulus, Department of Internal Medicine and Hematology, İstanbul, TurkeyUniversity of Health Sciences Turkey, Dr. Ersin Arslan Training and Research Hospital, Clinic of Internal Medicine, Gaziantep, Turkeyİstinye University Faculty of Medicine, Liv Hospital Ulus, Department of Internal Medicine and Hematology, İstanbul, TurkeyNecmettin Erbakan University Faculty of Medicine, Department of Hematology, Konya, TurkeyAlaattin Keykubat University Faculty of Medicine, Department of Hematology, Alanya, Turkeyİstanbul Medipol University Faculty of Medicine, İstanbul, Turkeyİstanbul Medipol University Faculty of Medicine, İstanbul, Turkeyİstanbul Medipol University Faculty of Medicine, İstanbul, Turkeyİstanbul Medipol University Faculty of Medicine, İstanbul, Turkeyİstanbul Medipol University Faculty of Medicine, Department of Hematology, İstanbul, TurkeyObjective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnaire Consisting of 30 Questions 'EORTC QLQ-C30' and the Quality of Life Questionnaire Multiple Myeloma Module 'QLQ-MY20', we aimed to obtain data on quality of life in MM patients in a representative sample of the general population of our country. Methods: One hundred sixty eight patients from 6 different centers followed between 2018-2020 were included in the study. The QLQ-C30, and the QLQ-MY20 questionnaires specific for MM patients were used and the results were reported statistically. Results: Seventy eight (46%) of the patients were female, while 90 (54%) were male. The median age was 64 (22-84). When the findings were analysed, it was found that there was a greater effect on the symptom scale compared to the functional scale. Conclusion: The importance of the treatment-related side effect management, together with the adequate administration of appropriate symptomatic treatment in holistic treatment management were emphasized as effective factors in terms of the QoL of patients with MM.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=forbes&un=FJM-04274multiple myelomaquality of lifechemotherapy |
| spellingShingle | Ali İhsan GEMİCİ İstemi SERİN Vedat Buğra EROL Mehmet Hilmi DOĞU İdris İNCE Rafet EREN Atakan TEKİNALP Volkan KARAKUŞ İklil Nur KOÇ EROL Zeynep Ece ARSLAN Zekiye Nur TAY Elif Nur TUNCER Ömür Gökmen SEVİNDİK Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study Forbes Tıp Dergisi multiple myeloma quality of life chemotherapy |
| title | Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study |
| title_full | Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study |
| title_fullStr | Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study |
| title_full_unstemmed | Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study |
| title_short | Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study |
| title_sort | quality of life assessment with eortc qlq in patients with multiple myeloma multicenter study |
| topic | multiple myeloma quality of life chemotherapy |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=forbes&un=FJM-04274 |
| work_keys_str_mv | AT aliihsangemici qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT istemiserin qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT vedatbugraerol qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT mehmethilmidogu qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT idrisince qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT rafeteren qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT atakantekinalp qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT volkankarakus qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT iklilnurkocerol qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT zeynepecearslan qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT zekiyenurtay qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT elifnurtuncer qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy AT omurgokmensevindik qualityoflifeassessmentwitheortcqlqinpatientswithmultiplemyelomamulticenterstudy |